| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |